摘要
表皮生长因子受体(EGFR)在食管癌中高表达或突变,引起肿瘤对放疗的抗拒,导致放疗效果差。抗EGFR治疗具有肿瘤放疗增敏作用,目前针对EGFR的分子靶向研究主要有人工合成的单克隆抗体、小分子酪氨酸激酶抑制剂、RNA干扰(RNAi)下调受体表达。
Epidermal growth factor receptor (EGFR) express highly or mutant in esophageal cancer, which causing tumor resistance to radiotherapy and leading to poor radiotherapeutic effects. Treatment with anti- EGFR can get radiosensitization. There are three main types of molecular targeted research for EGFR: synthetic monoclonal antibody, small molecule tyrosine kinase inhibitors, and other strategies modulating EGFR biosynthesis based on RNA interference.
出处
《国际肿瘤学杂志》
CAS
2012年第3期218-220,共3页
Journal of International Oncology
基金
基金项目:福建省医学创新课题资助计划项目(2007-CX-4)
关键词
食管肿瘤
受体
表皮生长因子
RNA干扰
Esophageal neoplasms
Receptor, epidermal growth factor
RNA interference